Back | Next |
home / stock / umrx / umrx message board
Subject | By | Source | When |
---|---|---|---|
* * $UMRX Video Chart 07-10-2020 * * | ClayTrader | investorshub | 07/10/2020 8:39:38 PM |
MONSTER!!!!! | PickleNick | investorshub | 07/08/2020 2:22:02 PM |
* * $UMRX Video Chart 07-07-2020 * * | ClayTrader | investorshub | 07/07/2020 8:23:57 PM |
$3.08 :D | wesley_ | investorshub | 07/07/2020 1:35:23 PM |
Beautiful | PickleNick | investorshub | 07/06/2020 10:09:06 PM |
hod $2.69 what a monster :-) | wesley_ | investorshub | 07/06/2020 9:09:47 PM |
* * $UMRX Video Chart 07-06-2020 * * | ClayTrader | investorshub | 07/06/2020 8:43:04 PM |
Sweet explosion $UMRX on news https://finance.yahoo.com/news/unum-therapeutics-in | $treet $inatra | investorshub | 07/06/2020 7:31:07 PM |
Today's shorties throw in the pot for lunch, | trendzone | investorshub | 07/06/2020 5:51:10 PM |
$2.18 nice runner | wesley_ | investorshub | 07/06/2020 5:25:18 PM |
$1.83 sweet | wesley_ | investorshub | 07/06/2020 3:55:22 PM |
$1.73 lovely :-) | wesley_ | investorshub | 07/06/2020 3:27:50 PM |
$1.42 nice | wesley_ | investorshub | 07/06/2020 3:05:56 PM |
$UMRX they voted on Monday,Anyone know if they | swanlinbar | investorshub | 06/10/2020 6:53:35 PM |
$UMRX out for now | swanlinbar | investorshub | 06/05/2020 4:00:20 PM |
$UMRX-Unum Therapeutics $UMRX Raised to Buy at Zacks | swanlinbar | investorshub | 06/04/2020 11:25:07 AM |
$UMRX Patience | swanlinbar | investorshub | 06/02/2020 1:51:40 PM |
$UMRX-Unum Therapeutics Inc (NASDAQ:$UMRX) Receives Consensus Recommendation of | swanlinbar | investorshub | 05/28/2020 8:19:06 PM |
$UMRX has been Churning here for awhile | swanlinbar | investorshub | 05/27/2020 5:40:28 PM |
https://www.stockscores.com/chart.asp?TickerSymbol=$UMRX&TimeRange=30&Interv | swanlinbar | investorshub | 05/26/2020 1:08:12 PM |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, Mass. and BOULDER, Colo., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced Andrew Robbins, Chief Executive Officer and President, wil...
Unum Therapeutics Announces Company Name Change to Cogent Biosciences, Highlights Recent Scientific and Operational Progress Cogent Biosciences is focused on the design of rational precision therapies to improve the lives of patients Company on track to advance CGT9486 into ...
SOTIO will establish a T cell therapy R&D Center of Excellence in Cambridge, Massachusetts Unum’s former chief technology officer Geoff Hodge to join SOTIO to lead BOXR development team and all research and development of the next generation T cell therapies Lead progra...